Wolverine Trading, LLC Global Blood Therapeutics, Inc. Transaction History

Wolverine Trading, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$32.46 - $43.42 $172,070 - $230,169	-5,301 Reduced 42.2%	7,260 $236,000
Q1 2021 May 14, 2021	SELL	$38.94 - $50.85 $448,705 - $585,944	-11,523 Reduced 47.85%	12,561 $512,000
Q4 2020 Feb 12, 2021	BUY	$37.65 - $63.77 $490,090 - $830,094	13,017 Added 117.62%	24,084 $1.07 Million
Q3 2020 Nov 13, 2020	BUY	$52.76 - $74.49 $583,894 - $824,380	11,067 New	11,067 $597,000
Q2 2020 Aug 13, 2020	SELL	$48.73 - $81.82 $1.35 Million - $2.26 Million	-27,672 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$41.72 - $87.2 $832,856 - $1.74 Million	19,963 Added 258.96%	27,672 $1.44 Million
Q4 2019 Feb 12, 2020	BUY	$45.7 - $81.86 $12,658 - $22,675	277 Added 3.73%	7,709 $610,000
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $7,392 - $9,439	-163 Reduced 2.15%	7,432 $366,000
Q2 2019 Aug 20, 2019	SELL	$52.6 - $63.29 $24,459 - $29,429	-465 Reduced 5.77%	7,595 $399,000
Q1 2019 May 15, 2019	SELL	$39.99 - $53.48 $497,275 - $665,023	-12,435 Reduced 60.67%	8,060 $427,000
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $412,101 - $609,790	13,066 Added 175.88%	20,495 $820,000
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $282,302 - $379,621	7,429 New	7,429 $282,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.